We are committed to investigating potential new therapies for advanced #NSCLC, learn more: iovance.com/clinical-trial… #LungCancerAwarenessMonth #LCAM2024

Congratulations to the BTT trainees!

Iovance is ready for an exciting 2025! We continue to expect significant growth in line with our full-year revenue guidance for 2024 and 2025. Check out our latest corporate presentation: ir.iovance.com/news-events/ev…

This Black History Month, we honor African American dermatologists who paved the way for skin health research. By supporting diverse voices in dermatology, we accelerate scientific discovery and improve outcomes for all melanoma patients. #BlackHistoryMonth #HealthEquality

Please join us in welcoming Dan Kirby to Iovance in the newly created role of Chief Commercial Officer: ir.iovance.com/news-releases/…

Today Iovance reported fourth quarter and full year 2024 financial results and corporate updates. We will host an audio webcast at 4:30 pm ET, join live or listen to the replay: ir.iovance.com/news-releases/…

At Iovance, we recognize and celebrate the pivotal role women play in advancing science and innovation. #womeninbiotech #womenshistorymonth #womeninSTEM

Today Iovance reported first quarter 2025 financial results and corporate updates. We will host an audio webcast at 4:30 pm ET, join live or listen to the replay: ir.iovance.com/news-releases/…

5-yr results of our phase 2 study of lifileucel in advanced melanoma will be presented for the first time at #ASCO25. Learn more: ir.iovance.com/news-releases/…

Wisconsin man first to benefit from newly approved cancer drug jsonline.com/story/news/hea…

Throughout the year and especially during #MelanomaAwarenessMonth, we are committed to following the science to drive innovation for patients. Check out Melanoma Research's recent webinar on a clinical trial option: curemelanoma.org/blog/mra-meet-…

We're in for Chicago at #ASCO25! Visit us at Booth 14111 or check out our presentation or poster: ir.iovance.com/news-releases/…

The Industry Breakthrough nominees include: ⭐ImmunityBio, Inc. ⭐BeOne Medicines ⭐Iovance Biotherapeutics ⭐Bristol-Myers Squibb ⭐Jazz Pharmaceuticals ⭐Servier Pharmaceuticals ⭐genetech Join our hosts, Shikha Jain MD, FACP & Edward S. Kim, MD, MBA, FACP, FASCO, as they unveil the winner!🏆 Visit Healio.com/Innovators to RSVP.

We’re excited to welcome Dan Kirby, Chief Commercial Officer at Iovance Biotherapeutics to #AdTherapiesUSA! Don’t miss your chance to hear from him on November 17th, during the opening plenary session at terrapinn.com/adtusa26/regis…

☀️ July marks the start of #UVSafetyMonth, an important summer reminder to protect your skin not just on sunny days, but all year round! Did you know there are two main types of ultraviolet rays that can harm your skin? • UVA rays age skin cells and can cause long-term damage

Soak up the fun, not the rays! ☀️🧴 This summer, pack your beach bag with sunscreen, UPF clothing, a wide-brimmed hat, sunglasses, and make sure to seek out shade. Remember, every bit of sun protection counts, as sun damage is cumulative and accumulates over time. Protect your

🫁 Lung cancer is the leading cause of cancer death worldwide. On #WorldLungCancerDay, we reaffirm our commitment to changing the way cancer is treated. 🔬 Learn about our lung cancer clinical trial: tilcelltherapy.com/clinical-trial… #LungCancerResearch #WorldLungCancerDay #NSCLC

We are honored to present the SITC Medal of Honor to Marc Theoret for his incredible partnership while at the FDA. This award recognizes his stewardship of innovative regulatory approaches to immuno-oncology drug development and approval. LEARN MORE: sitcancer.org/about/awards#s…

We’re beyond thankful to our phenomenal Denver Gala Co-Chairs Wendy and Bruce Glazer, Parth K. Shah, MD and Shawn E. Young, MD for their incredible vision, leadership and heart. Your dedication is paving the way for an extraordinary evening in support of the melanoma community.

We're excited to share that we received our first marketing authorization outside the U.S. for our cell therapy in advanced melanoma. Learn more: ir.iovance.com/news-releases/…